Cytotoxic CD4+ T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate Trypanosoma cruzi-infected hearts

  1. Carlos-Henrique D Barbosa
  2. Fabio B Canto
  3. Ariel Gomes
  4. Layza M Brandao
  5. Jéssica R Lima
  6. Guilherme A Melo
  7. Alessandra Granato
  8. Eula GA Neves
  9. Walderez O Dutra
  10. Ana-Carolina Oliveira
  11. Alberto Nóbrega
  12. Maria Bellio  Is a corresponding author
  1. Rosalind Franklin University of Medicine and Science, United States
  2. Universidade Federal Fluminense, Brazil
  3. Universidade Federal do Rio de Janeiro (UFRJ), Brazil
  4. Universidade Federal de Minas Gerais, Brazil

Abstract

Increasing attention has been directed to cytotoxic CD4+ T cells (CD4CTLs) in different pathologies, both in humans and mice. The impact of CD4CTLs in immunity and the mechanisms controlling their generation, however, remain poorly understood. Here, we show that CD4CTLs abundantly differentiate during mouse infection with the intracellular parasite Trypanosoma cruzi. CD4CTLs display parallel kinetics to Th1 cells in the spleen, mediate specific cytotoxicity against cells presenting pathogen-derived antigens and express immunoregulatory and/or exhaustion markers. We demonstrate that CD4CTL absolute numbers and activity are severely reduced in both Myd88-/- and Il18ra-/- mice. Of note, the infection of mixed-bone marrow chimeras revealed that WT but not Myd88-/- cells transcribe the CD4CTL gene signature and that Il18ra-/- and Myd88-/- CD4+ T cells phenocopy each other. Moreover, adoptive transfer of WT CD4+GzB+ T cells to infected Il18ra-/- mice extended their survival. Importantly, cells expressing the CD4CTL phenotype predominate among CD4+ T cells infiltrating the infected mouse cardiac tissue and are increased in the blood of Chagas patients, in which the frequency of CD4CTLs correlates with the severity of cardiomyopathy. Our findings describe CD4CTLs as a major player in immunity to a relevant human pathogen and disclose T-cell intrinsic IL-18R/MyD88 signaling as a key pathway controlling the magnitude of the CD4CTL response.

Data availability

Transcriptome data was uploaded to GEO and is already publicly available with the GEO accession no. GSE57738

The following previously published data sets were used

Article and author information

Author details

  1. Carlos-Henrique D Barbosa

    Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7644-7034
  2. Fabio B Canto

    Departamento de Imunobiologia, Universidade Federal Fluminense, Niteroi, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  3. Ariel Gomes

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  4. Layza M Brandao

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  5. Jéssica R Lima

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  6. Guilherme A Melo

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  7. Alessandra Granato

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  8. Eula GA Neves

    Laboratório de Biologia das Interações Celulares, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  9. Walderez O Dutra

    Laboratório de Biologia das Interações Celulares, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  10. Ana-Carolina Oliveira

    Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0036-3720
  11. Alberto Nóbrega

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    Competing interests
    The authors declare that no competing interests exist.
  12. Maria Bellio

    Department of Immunology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
    For correspondence
    mariabellioufrj@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3360-2740

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (CNE Award E-26/202.603/2019)

  • Maria Bellio

Conselho Nacional de Desenvolvimento Científico e Tecnológico (PQ Award 312143/2018-4)

  • Maria Bellio

Conselho Nacional de Desenvolvimento Científico e Tecnológico (INCT -V 465293/2014-0)

  • Maria Bellio

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)

  • Maria Bellio

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mouse experiments were conducted in accordance with guidelines of the Animal Care and Use Committee of the Federal University of Rio de Janeiro (Comitê de Ética do Centro de Ciências da Saúde CEUA - CCS/UFRJ, license: IMPPG022).

Human subjects: All individuals included in this work were volunteers and treatment and clinical care were offered to all patients, as needed, despite their enrollment in this research project. All participants provided written informed consent for participation in the study. This cross-sectional study is part of an extended project evaluating biomarkers of cardiomyopathy development in Chagas disease, which has the approval of the National Committee of Ethics in Research (CONEP#195/2007) and are in accordance with the Declaration for Helsinki.

Copyright

© 2022, Barbosa et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,633
    views
  • 304
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carlos-Henrique D Barbosa
  2. Fabio B Canto
  3. Ariel Gomes
  4. Layza M Brandao
  5. Jéssica R Lima
  6. Guilherme A Melo
  7. Alessandra Granato
  8. Eula GA Neves
  9. Walderez O Dutra
  10. Ana-Carolina Oliveira
  11. Alberto Nóbrega
  12. Maria Bellio
(2022)
Cytotoxic CD4+ T cells driven by T-cell intrinsic IL-18R/MyD88 signaling predominantly infiltrate Trypanosoma cruzi-infected hearts
eLife 11:e74636.
https://doi.org/10.7554/eLife.74636

Share this article

https://doi.org/10.7554/eLife.74636

Further reading

    1. Immunology and Inflammation
    Denise M Monack
    Insight

    Macrophages control intracellular pathogens like Salmonella by using two caspase enzymes at different times during infection.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Ainhoa Arbués, Sarah Schmidiger ... Damien Portevin
    Research Article

    The members of the Mycobacterium tuberculosis complex (MTBC) causing human tuberculosis comprise 10 phylogenetic lineages that differ in their geographical distribution. The human consequences of this phylogenetic diversity remain poorly understood. Here, we assessed the phenotypic properties at the host-pathogen interface of 14 clinical strains representing five major MTBC lineages. Using a human in vitro granuloma model combined with bacterial load assessment, microscopy, flow cytometry, and multiplexed-bead arrays, we observed considerable intra-lineage diversity. Yet, modern lineages were overall associated with increased growth rate and more pronounced granulomatous responses. MTBC lineages exhibited distinct propensities to accumulate triglyceride lipid droplets—a phenotype associated with dormancy—that was particularly pronounced in lineage 2 and reduced in lineage 3 strains. The most favorable granuloma responses were associated with strong CD4 and CD8 T cell activation as well as inflammatory responses mediated by CXCL9, granzyme B, and TNF. Both of which showed consistent negative correlation with bacterial proliferation across genetically distant MTBC strains of different lineages. Taken together, our data indicate that different virulence strategies and protective immune traits associate with MTBC genetic diversity at lineage and strain level.